BioRestorative Therapies
BRTX
15 hedge funds and large institutions have $849K invested in BioRestorative Therapies in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 2 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
0.98% less ownership
Funds ownership: 9.41% → 8.43% (-0.98%)
6% less funds holding
Funds holding: 16 → 15 (-1)
23% less capital invested
Capital invested by funds: $1.11M → $849K (-$259K)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
+$15.7K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$6K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$4.31K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$19 |
| 5 |
Wells Fargo
San Francisco,
California
|
+$3 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Ayrton Capital
Westport,
Connecticut
|
-$62.4K |
| 2 |
BFM
Boothbay Fund Management
New York
|
-$61.4K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$4.88K |
| 4 |
SPIA
Steward Partners Investment Advisory
New York
|
-$3.11K |
| 5 |
IA
IFP Advisors
Tampa,
Florida
|
-$2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Vanguard Group
Malvern,
Pennsylvania
| $371K | – | – | – |
|
|
WA
2
Wealth Alliance
Mellville,
New York
| $122K | – | – | – |
|
|
AC
3
Ayrton Capital
Westport,
Connecticut
| $114K | -$62.4K | -20,044 | -33% |
|
|
4
Cambridge Investment Research Advisors
Fairfield,
Iowa
| $77K | +$15.7K | +5,050 | +22% |
|
5
Mariner
Overland Park,
Kansas
| $73K | – | – | – |
|
|
6
Geode Capital Management
Boston,
Massachusetts
| $37K | +$4.31K | +1,385 | +11% |
|
|
BFM
7
Boothbay Fund Management
New York
| $33.8K | -$61.4K | -19,704 | -62% |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| $11K | +$6K | +1,927 | +85% |
|
|
SPIA
9
Steward Partners Investment Advisory
New York
| $5.5K | -$3.11K | -1,000 | -33% |
|
10
Osaic Holdings
Scottsdale,
Arizona
| $5K | – | – | – |
|
|
11
Wells Fargo
San Francisco,
California
| $61 | +$3 | +1 | +5% |
|
|
12
Bank of America
Charlotte,
North Carolina
| $16 | +$19 | +6 | New |
|
|
13
UBS Group
Zurich,
Switzerland
| $3 | -$4.88K | -1,566 | -100% |
|
|
JWM
14
Janiczek Wealth Management
Denver,
Colorado
| $3 | – | – | – |
|
|
IA
15
IFP Advisors
Tampa,
Florida
| – | -$2K | -2 | Closed |
|
BRTX Hedge Fund Activity: Q4 2022 in Review
15 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in BioRestorative Therapies (BRTX) for Q4 2022, worth a combined $849K — down 23% from $1.11M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of BRTX and 1 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 4 added.
The largest buyer was Cambridge Investment Research Advisors, adding an estimated $15.7K. The largest seller was Ayrton Capital, cutting an estimated $62.4K.
- 15 institutional investors held BioRestorative Therapies (BRTX) as of Q4 2022, down from 16 in Q3 2022.
- Funds reported $849K of BioRestorative Therapies stock for Q4 2022, down 23% quarter-over-quarter.
- 1 fund opened new BioRestorative Therapies positions in Q4 2022 and 2 closed out, a net change of -1 holder.
- The largest BioRestorative Therapies buyer in Q4 2022 was Cambridge Investment Research Advisors, an estimated $15.7K added.
- The largest BioRestorative Therapies seller in Q4 2022 was Ayrton Capital, an estimated $62.4K sold.
Based on aggregated 13F filings for Q4 2022.